Nirmidas Biotech
PrivateLast Round
Grant
Mar 27, 2017
Total Funding Raised
$4.49M
Company Overview
Nirmidas Biotech operates in Healthcare & Life Sciences and is based in Mountain View, California. Its latest recorded funding round was a Grant round in March 2017.
Nirmidas Biotech is a biotechnology company that develops and commercializes advanced diagnostic and imaging products, including test kits, fluorescent probes, and in vivo imaging systems for life science research and clinical applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Biotech Equipment, Medical Imaging
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nirmidas Biotech Comparables
Compare Nirmidas Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mars, Incorporated | 80% | |
| Micropoint Biotechnologies | 78% | |
| Achira Labs Private Limited | 78% |
For institutional investors. Book with your work email.
Nirmidas Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 27, 2017 | ||||
| Seed | Aug 18, 2014 |
For institutional investors. Book with your work email.
Nirmidas Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 20, 2026
Monthly visitors increased 52% MoM.
- Nov 8, 2025
Monthly visitors grew 83% MoM, reaching 1.1K.
For institutional investors. Book with your work email.
Nirmidas Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Nirmidas Biotech's valuation, stock price, and market status.
Is Nirmidas Biotech a public or private company?
Nirmidas Biotech is a private company.
What is the current stock price of Nirmidas Biotech?
Nirmidas Biotech is a private company, so its shares have no public market price. Caplight tracks Nirmidas Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nirmidas Biotech worth (valuation)?
Valuation information for Nirmidas Biotech is not publicly available.
Can I buy Nirmidas Biotech stock?
Nirmidas Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nirmidas Biotech's last funding round?
Nirmidas Biotech's most recent funding round was Grant on March 27, 2017.
Who are the main investors in Nirmidas Biotech?
Key investors in Nirmidas Biotech include NIH RADx.
Will Nirmidas Biotech IPO soon?
No public IPO plans have been announced for Nirmidas Biotech.
How can I track Nirmidas Biotech secondary market activity?
Caplight tracks bids, offers, and trades in Nirmidas Biotech's shares on secondary markets.